Find Research Outputs

Search results

• 2013

  A C-type lectin receptor pathway is responsible for the pathogenesis of acute cyclophosphamide-induced cystitis in mice

  Dejima, T., Shibata, K., Yamada, H., Takeuchi, A., Hara, H., Eto, M., Naito, S. & Yoshikai, Y., Dec 2013, In: MICROBIOLOGY and IMMUNOLOGY. 57, 12, p. 833-841 9 p.

  Research output: Contribution to journal › Article › peer-review

  • C-Type Lectins
  • Cystitis
  • Interleukin-17
  • Cyclophosphamide
  • Caspase Activation and Recruitment Domain
  1 Citation (Scopus)

• Benign tumors of the kidney to differentiate from malignant renal cancer

  Wada, Y., Takahashi, W., Kawano, Y. & Eto, M., Oct 1 2013, In: Japanese Journal of Clinical Urology. 67, 11, p. 853-862 10 p.

  Research output: Contribution to journal › Article › peer-review

• Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88)

  Nitta, H., Wada, Y., Kawano, Y., Murakami, Y., Irie, A., Taniguchi, K., Kikuchi, K., Yamada, G., Suzuki, K., Honda, J., Wilson-Morifuji, M., Araki, N., Eto, M., Baba, H. & Imamura, T., Apr 15 2013, In: Clinical Cancer Research. 19, 8, p. 2004-2013 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Anaphylatoxin C5a Receptor
  • Anaphylatoxins
  • Cell Movement
  • Neoplasms
  • Matrix Metalloproteinases
  52 Citations (Scopus)

• Establishment of HLA-DR4 transgenic mice for the identification of CD4 ⁺ T cell epitopes of tumor-associated antigens

  Yatsuda, J., Irie, A., Harada, K., Michibata, Y., Tsukamoto, H., Senju, S., Tomita, Y., Yuno, A., Hirayama, M., Sayem, M. A., Takeda, N., Shibuya, I., Sogo, S., Fujiki, F., Sugiyama, H., Eto, M. & Nishimura, Y., Dec 30 2013, In: PloS one. 8, 12, e84908.

  Research output: Contribution to journal › Article › peer-review

  • HLA-DRB1*04:01 antigen
  • T-Lymphocyte Epitopes
  • Neoplasm Antigens
  • Tumors
  • epitopes
  3 Citations (Scopus)

• Fact-finding surveillance of patients with interstitial cystitis in the Kyushu area - 16th Kyushu cooperative urological research

  Hayami, H., Nakagawa, M., Enokida, H., Naito, S., Yokomizo, A., Uozumi, J., Noguchi, M., Eto, M., Wada, Y., Nishi, K., Sakai, H., Igawa, T., Nishikido, M., Matsumoto, T., Fujimoto, N., Saito, S., Oshiro, Y., Matsuoka, K., Noguchi, M., Suekane, S. & 7 others, Mimata, H., Sato, F., Tanaka, M., Matsuoka, H., Hiratsuka, Y., Ishii, T. & Kamoto, T., Oct 2013, In: Nishinihon Journal of Urology. 75, 10, p. 522-531 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Interstitial Cystitis
  • Intravesical Administration
  • Japan
  • Therapeutics
  • Urinary Bladder
  1 Citation (Scopus)

• IJU this issue

  Eto, M., Nov 2013, In: International Journal of Urology. 20, 11, p. 1051 1 p.

  Research output: Contribution to journal › Editorial › peer-review

• Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: A multi-institutional retrospective study in Japan

  Hirono, M., Kobayashi, M., Tsushima, T., Obara, W., Shinohara, N., Ito, K., Eto, M., Takayama, T., Fujii, Y., Nishikido, M., Kimura, G., Kishida, T., Takahashi, M., Miyao, N., Naya, Y., Abe, T., Fujioka, T., Ito, K. & Naito, S., Oct 2 2013, In: BMC Cancer. 13, 447.

  Research output: Contribution to journal › Article › peer-review

  • Renal Cell Carcinoma
  • Japan
  • Thrombosis
  • Retrospective Studies
  • Survival
  9 Citations (Scopus)

• Molecular targeted therapy for the treatment of renal cancer: Current state and issues

  Wada, Y., Takahashi, W., Kawano, Y., Sugiyama, Y., Tanoue, K. & Eto, M., Oct 2013, In: Nishinihon Journal of Urology. 75, 10, p. 514-521 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Molecular Targeted Therapy
  • Kidney Neoplasms
  • Survival
  • Progression-Free Survival
  • TYK2 Kinase

• Renal carcinoma surveillance counterpoint: Japan

  Eto, M., Takahashi, W., Kawano, Y., Honda, J., Nakanishi, J. & Wada, Y., Jan 1 2013, Patient Surveillance After Cancer Treatment. Humana Press Inc., p. 381-382 2 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• STAT3 polymorphism can predict the response to interferon-α Therapy in patients with metastatic renal cell carcinoma

  Eto, M., Kamba, T., Miyake, H., Fujisawa, M., Kamai, T., Uemura, H., Tsukamoto, T., Azuma, H., Matsubara, A., Nishimura, K., Nakamura, T., Ogawa, O. & Naito, S., Apr 2013, In: European Urology. 63, 4, p. 745-752 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Renal Cell Carcinoma
  • Interferons
  • Single Nucleotide Polymorphism
  • STAT3 Transcription Factor
  • Therapeutics
  25 Citations (Scopus)

• YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α

  Takeuchi, A., Shiota, M., Tatsugami, K., Yokomizo, A., Kuroiwa, K., Dejima, T., Tanaka, S., Itsumi, M., Eto, M. & Naito, S., Mar 2013, In: Cancer Immunology, Immunotherapy. 62, 3, p. 517-527 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Kidney Neoplasms
  • Transducers
  • Proteolysis
  • Interferons
  • Renal Cell Carcinoma
  12 Citations (Scopus)
• 2015

  C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways

  Maeda, Y., Kawano, Y., Wada, Y., Yatsuda, J., Motoshima, T., Murakami, Y., Kikuchi, K., Imamura, T. & Eto, M., Apr 1 2015, In: Oncology reports. 33, 4, p. 1844-1850 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Anaphylatoxin C5a Receptor
  • Phosphatidylinositol 3-Kinases
  • Renal Cell Carcinoma
  • Anaphylatoxins
  • Anoikis
  23 Citations (Scopus)

• Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association

  Kanayama, H. O., Fukumori, T., Fujimoto, H., Nakanishi, H., Ohyama, C., Suzuki, K., Nishiyama, H., Eto, M., Miki, T., Kamoi, K., Kubota, Y., Takahashi, S., Homma, Y. & Naito, S., Sep 1 2015, In: International Journal of Urology. 22, 9, p. S1-S7

  Research output: Contribution to journal › Article › peer-review

  • Renal Cell Carcinoma
  • Multicenter Studies
  • Neoplasms
  • Japan
  • Survival Rate
  13 Citations (Scopus)

• III. Topics of chemotherapy

  Murakami, Y. & Eto, M., Jan 1 2015, In: Gan to kagaku ryoho. Cancer & chemotherapy. 42, 1, p. 36-40 5 p.

  Research output: Contribution to journal › Article › peer-review

• IJU this issue

  Eto, M., Mar 1 2015, In: International journal of urology : official journal of the Japanese Urological Association. 22, 3, p. 241 1 p.

  Research output: Contribution to journal › Editorial › peer-review

• Impact of smoking on the age at diagnosis of upper tract urothelial carcinoma: Subanalysis of the Japanese Urological Association multi-institutional national database

  Cancer Registration Committee of the Japanese Urological Association, Nov 2015, In: International Journal of Urology. 22, 11, p. 1023-1027 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Smoking
  • Carcinoma
  • Databases
  • Smokers
  • Early Diagnosis
  6 Citations (Scopus)

• Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma

  Naito, S., Sakai, H., Hashine, K., Tomita, Y., Shinohara, N., Fujisawa, M., Eto, M., Ozono, S. & Akaza, H., Sep 1 2015, In: Annals of Oncology. 26, 9, p. 1871-1876 6 p., mdv280.

  Research output: Contribution to journal › Article › peer-review

  • S 1 (combination)
  • Sorafenib
  • Renal Cell Carcinoma
  • Maximum Tolerated Dose
  • Foot

• Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan

  and Japan RCC Trialist Collaborative Group (JRTCG) investigators, Oct 9 2015, In: BMC Cancer. 15, 1, 667.

  Research output: Contribution to journal › Article › peer-review

  • Sorafenib
  • Phase II Clinical Trials
  • Interferon-alpha
  • Renal Cell Carcinoma
  • Japan
  8 Citations (Scopus)

• Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association

  Cancer Registration Committee of the Japanese Urological Association, Nov 2015, In: International Journal of Urology. 22, 11, p. 1013-1020 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Urologic Neoplasms
  • Nephroureterectomy
  • Databases
  • Proportional Hazards Models
  • Recurrence
  6 Citations (Scopus)

• Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantation

  Takeuchi, A., Eto, M., Tatsugami, K., Yamada, H., Yokomizo, A., Shiota, M., Itsumi, M., Inokuchi, J., Kiyoshima, K., Dejima, T., Imada, K., Naito, S. & Yoshikai, Y., Mar 1 2015, In: Transplant Immunology. 32, 2, p. 131-139 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Kidney Neoplasms
  • Allogeneic Cells
  • Stem Cell Transplantation
  • Graft vs Host Disease
  • Lymphocytes
  3 Citations (Scopus)

• Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era

  on behalf of the Japanese Society of Renal Cancer, Aug 1 2015, In: International Journal of Urology. 22, 8, p. 736-740 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Nephrectomy
  • Renal Cell Carcinoma
  • Cytokines
  • Survival
  • Karnofsky Performance Status
  11 Citations (Scopus)

• Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells

  Motoshima, T., Komohara, Y., Horlad, H., Takeuchi, A., Maeda, Y., Tanoue, K., Kawano, Y., Harada, M., Takeya, M. & Eto, M., Jun 1 2015, In: Oncology reports. 33, 6, p. 2947-2953 7 p.

  Research output: Contribution to journal › Article › peer-review

  • CTLA-4 Antigen
  • Myeloid-Derived Suppressor Cells
  • Sorafenib
  • Antibodies
  • Neoplasms
  15 Citations (Scopus)
• 2016

  Adenocarcinoma in a urethral diverticulum where preoperative diagnosis was difficult: A case report

  Anami, T., Sameshima, T., Murakami, Y., Yatsuda, J., Sakakida, H., Yamaguchi, T., Tanoue, K. I., Sugiyama, Y., Kawano, Y., Eto, M. & Takahashi, W., Oct 2016, In: Nishinihon Journal of Urology. 78, 10, p. 510-513 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Diverticulum
  • Adenocarcinoma
  • Pelvic Exenteration
  • Gynecological Examination
  • Vagina

• Aldehyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 1B (ADH1B) polymorphisms exacerbate bladder cancer risk associated with alcohol drinking: Gene-environment interaction

  Masaoka, H., Ito, H., Soga, N., Hosono, S., Oze, I., Watanabe, M., Tanaka, H., Yokomizo, A., Hayashi, N., Eto, M. & Matsuo, K., Jun 4 2016, In: Carcinogenesis. 37, 6, p. 583-588 6 p., bgw033.

  Research output: Contribution to journal › Article › peer-review

  • Aldehyde Dehydrogenase
  • Alcohol Dehydrogenase
  • Gene-Environment Interaction
  • Urinary Bladder Neoplasms
  • Alcohol Drinking
  18 Citations (Scopus)

• An open-label, randomized phase II trial of personalized peptide vaccination in patients with bladder cancer that progressed after platinum-based chemotherapy

  Noguchi, M., Matsumoto, K., Uemura, H., Arai, G., Eto, M., Naito, S., Ohyama, C., Nasu, Y., Tanaka, M., Moriya, F., Suekane, S., Matsueda, S., Komatsu, N., Sasada, T., Yamada, A., Kakuma, T. & Itoh, K., Jan 1 2016, In: Clinical Cancer Research. 22, 1, p. 54-60 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Platinum
  • Urinary Bladder Neoplasms
  • Vaccination
  • Peptides
  • Drug Therapy
  32 Citations (Scopus)

• Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer

  Takeuchi, A., Eto, M., Tatsugami, K., Shiota, M., Yamada, H., Kamiryo, Y., Dejima, T., Kashiwagi, E., Kiyoshima, K., Inokuchi, J., Takahashi, R., Yokomizo, A., Ohara, N. & Yoshikai, Y., Jun 2016, In: International Immunopharmacology. 35, p. 327-331 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Interleukin-15
  • Bacillus
  • Urinary Bladder Neoplasms
  • Proteins
  • Urinary Bladder
  6 Citations (Scopus)

• BCG Immunotherapy Against Non-Muscle Invasive Bladder Cancer: Recent Results, Current Studies and Future Perspectives

  Takeuchi, A., Shiota, M., Tatsugami, K., Yokomizo, A. & Eto, M., Jan 1 2016, In: Fukuoka igaku zasshi = Hukuoka acta medica. 107, 1, p. 8-11 4 p.

  Research output: Contribution to journal › Review article › peer-review

• C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy

  Wada, Y., Maeda, Y., Kubo, T., Kikuchi, K., Eto, M. & Imamura, T., Nov 2016, In: Oncology Letters. 12, 5, p. 3995-4000 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Nephroureterectomy
  • Cystectomy
  • Anaphylatoxin C5a Receptor
  • Carcinoma
  • Confidence Intervals
  9 Citations (Scopus)

• Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare

  Shiota, M., Yokomizo, A., Takeuchi, A., Kiyoshima, K., Inokuchi, J., Tatsugami, K., Shiga, K. I., Koga, H., Yamaguchi, A., Naito, S. & Eto, M., Dec 1 2016, In: BJU international. 118, 6, p. 880-884 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Docetaxel
  • Castration
  • Prostate-Specific Antigen
  • Prostatic Neoplasms
  • Steroids
  4 Citations (Scopus)

• Current Status and Future Perspective of Tolerance Induction in Patients with Kidney Transplantation

  Eto, M. & Takeuchi, A., Apr 1 2016, In: Fukuoka igaku zasshi = Hukuoka acta medica. 107, 4, p. 63-71 9 p.

  Research output: Contribution to journal › Review article › peer-review
  1 Citation (Scopus)

• Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer

  Shiota, M. & Eto, M., May 1 2016, In: International Journal of Urology. 23, 5, p. 360-369 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Prostatic Neoplasms
  • Hormones
  • Drug Therapy
  • Androgens
  • Taxoids
  36 Citations (Scopus)

• CXCL10 and CCL2 mRNA expression in monocytes is inversely correlated with the HLA-DR lower fraction of monocytes in patients with renal cell carcinoma

  Motoshima, T., Komohara, Y., Horlad, H., Tsukamoto, H., Fujita, M., Saito, Y., Tanoue, K., Kasejima, Y., Sugiyama, Y., Kawano, Y., Nishimura, Y., Takeya, M. & Eto, M., Mar 2016, In: Oncology Letters. 11, 3, p. 1911-1916 6 p.

  Research output: Contribution to journal › Article › peer-review

  • HLA Antigens
  • Renal Cell Carcinoma
  • Monocytes
  • Ligands
  • Messenger RNA
  5 Citations (Scopus)

• Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: Sub-analysis of the multi-institutional national database of the Japanese Urological Association

  Cancer Registration Committee of the Japanese Urological Association, 2016, In: Japanese journal of clinical oncology. 46, 5, p. 468-474 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Japan
  • Databases
  • Urinary Tract
  • Drug Therapy
  • Neoplasms

• Effects of switching from alpha-blocker to tadalafil in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (kyu-pro study)

  Miyazato, M., Oshiro, T., Saito, S., Takahashi, R., Eto, M., Nishii, H., Fujimoto, N., Sumino, Y., Mimata, H., Arai, K. & Kinjo, T., Aug 2016, In: Nishinihon Journal of Urology. 78, 8, p. 398-405 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Tadalafil
  • Lower Urinary Tract Symptoms
  • Prostatic Hyperplasia
  • Prostate
  • Overactive Urinary Bladder
  1 Citation (Scopus)

• Efficiency and safety of melatonin receptor agonist for treatment of nocturia

  Obata, H., Takahashi, R., Eto, M., Yunoki, T. & Tomoda, T., Oct 2016, In: Nishinihon Journal of Urology. 78, 10, p. 493-498 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Melatonin Receptors
  • Nocturia
  • ramelteon
  • Sleep Initiation and Maintenance Disorders
  • Safety

• Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2

  Itsumi, M., Shiota, M., Takeuchi, A., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Kajioka, S., Uchiumi, T., Naito, S., Eto, M. & Yokomizo, A., Jul 1 2016, In: Cancer Science. 107, 7, p. 1022-1028 7 p.

  Research output: Contribution to journal › Article › peer-review

  • S-Phase Kinase-Associated Proteins
  • Equol
  • Androgen Receptors
  • Isoflavones
  • Prostatic Neoplasms
  18 Citations (Scopus)

• External validation of preoperative nomograms predicting lymph node involvement in patients who underwent extended pelvic lymph node dissection during robot-assisted radical prostatectomy

  Inokuchi, J., Namitome, R., Kiyoshima, K., Takeuchi, A., Shiota, M., Takahashi, R., Tatsugami, K., Yokomizo, A. & Eto, M., Sep 2016, In: Nishinihon Journal of Urology. 78, 9, p. 451-456 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Nomograms
  • Prostatectomy
  • Lymph Node Excision
  • Lymph Nodes
  • Japan

• Greeting from new appointees

  Eto, M., Jan 1 2016, In: Nishinihon Journal of Urology. 78, 1, p. 1-2 2 p.

  Research output: Contribution to journal › Editorial › peer-review

• Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association

  on behalf of the Cancer Registration Committee of the Japanese Urological Association, Mar 1 2016, In: International Journal of Urology. 23, 3, p. 224-230 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Urologic Neoplasms
  • Combined Modality Therapy
  • Survival
  • Neoplasm Metastasis
  • Drug Therapy
  6 Citations (Scopus)

• Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma

  Ma, C., Komohara, Y., Ohnishi, K., Shimoji, T., Kuwahara, N., Sakumura, Y., Matsuishi, K., Fujiwara, Y., Motoshima, T., Takahashi, W., Yamada, S., Kitada, S., Fujimoto, N., Nakayama, T., Eto, M. & Takeya, M., May 1 2016, In: Cancer Science. 107, 5, p. 700-707 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Renal Cell Carcinoma
  • Macrophages
  • Neoplasms
  • Neoplastic Stem Cells
  • Tumor Necrosis Factor-alpha
  19 Citations (Scopus)

• Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan

  Takahashi, S., Hamasuna, R., Yasuda, M., Ishikawa, K., Hayami, H., Uehara, S., Yamamoto, S., Minamitani, S., Kadota, J., Iwata, S., Kaku, M., Watanabe, A., Sato, J., Hanaki, H., Masumori, N., Kiyota, H., Egawa, S., Tanaka, K., Arakawa, S., Fujisawa, M. & 43 others, Kumon, H., Wada, K., Kobayashi, K., Matsubara, A., Matsumoto, T., Eto, M., Tatsugami, K., Kuroiwa, K., Ito, K., Hosobe, T., Hirayama, H., Narita, H., Yamaguchi, T., Ito, S., Sumii, T., Kawai, S., Kanokogi, M., Kawano, H., Chokyu, H., Uno, S., Monden, K., Kaji, S., Kawahara, M., Takayama, K., Ito, M., Yoshioka, M., Kano, M., Konishi, T., Kadena, H., Nishi, S., Nishimura, H., Yamauchi, T., Maeda, S., Horie, M., Ihara, H., Matsumura, M., Shirane, T., Takeyama, K., Akiyama, K., Takahashi, K., Ikuyama, T., Inatomi, H. & Yoh, M., Sep 1 2016, In: Journal of Infection and Chemotherapy. 22, 9, p. 581-586 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Urethritis
  • Chlamydia trachomatis
  • Sexually Transmitted Diseases
  • sitafloxacin
  • Japan
  10 Citations (Scopus)

• Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy

  Kawano, Y., Takahashi, W., Eto, M., Kamba, T., Miyake, H., Fujisawa, M., Kamai, T., Uemura, H., Tsukamoto, T., Azuma, H., Matsubara, A., Nishimura, K., Nakamura, T., Ogawa, O. & Naito, S., Jul 1 2016, In: Cancer Science. 107, 7, p. 1013-1017 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Molecular Targeted Therapy
  • Renal Cell Carcinoma
  • Interferons
  • Survival
  • Hypercalcemia
  8 Citations (Scopus)

• Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder Cancer

  Kiyoshima, K., Akitake, M., Shiota, M., Takeuchi, A., Takahashi, R., Inokuchi, J., Tatsugami, K., Yokomizo, A. & Eto, M., Feb 1 2016, In: Anticancer research. 36, 2, p. 799-802 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Urinary Bladder Neoplasms
  • Cell Biology
  • Urine
  • Recurrence
  • Confidence Intervals
  9 Citations (Scopus)

• Proper use of novel agents for castration-resistant prostate cancer

  Shiota, M., Yokomizo, A. & Eto, M., May 2016, In: Nishinihon Journal of Urology. 78, 5, p. 221-228 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Castration
  • Prostatic Neoplasms
  • Patient Selection
  • cabazitaxel
  • abiraterone

• Recent topics in the treatments of renal cell carcinoma

  Eto, M., Jan 1 2016, In: Japanese Journal of Cancer and Chemotherapy. 43, 1, p. 50-53 4 p.

  Research output: Contribution to journal › Article › peer-review

• Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer

  Shiota, M., Yokomizo, A., Takeuchi, A., Inokuchi, J., Tatsugami, K., Ohga, S., Sasaki, T., Nakamura, K., Honda, H. & Eto, M., Oct 1 2016, In: Japanese journal of clinical oncology. 46, 10, p. 952-957 6 p., hyw098.

  Research output: Contribution to journal › Article › peer-review

  • Urinary Bladder Neoplasms
  • Prostatic Neoplasms
  • Smoking
  • Radiotherapy
  • Prostatectomy
  4 Citations (Scopus)

• Taxane chemotherapy for hormone-naïve prostate cancer with its expanding role as breakthrough strategy

  Shiota, M., Yokomizo, A. & Eto, M., 2016, In: Frontiers in Oncology. 5, JAN, 304.

  Research output: Contribution to journal › Short survey › peer-review

  • taxane
  • Prostatic Neoplasms
  • Hormones
  • Drug Therapy
  • Castration
  16 Citations (Scopus)

• The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism

  Shiota, M., Fujimoto, N., Yokomizo, A., Takeuchi, A., Kashiwagi, E., Dejima, T., Kiyoshima, K., Inokuchi, J., Tatsugami, K. & Eto, M., Jun 1 2016, In: Prostate Cancer and Prostatic Diseases. 19, 2, p. 191-196 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Androgens
  • Testosterone
  • Prostatic Neoplasms
  • Serum
  • Survival
  18 Citations (Scopus)

• The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery

  Bigot, P., Bernhard, J. C., Gill, I. S., Vuong, N. S., Verhoest, G., Flamand, V., Reix, B., Suer, E., Gökce, I., Beauval, J. B., Nouhaud, F. X., Eto, M., Baco, E., Matsugasumi, T., Chowaniec, Y., Rigaud, J., Lenormand, C., Pfister, C., Hetet, J. F., Ploussard, G. & 17 others, Roupret, M., Léon, P., Bakri, A. E., Larré, S., Tillou, X., Doerfler, A., Descazeaud, A., Koutlidis, N., Schneider, A., Sebe, P., Ingels, A., Azzouzi, A. R., Soulié, M., Méjean, A., Bensalah, K., Patard, J. J. & the members of the Kidney Cancer group of the CCAFU, M. O. T. K. C. G. O. T. CCAFU., Mar 1 2016, In: World Journal of Urology. 34, 3, p. 347-352 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Nephrons
  • Renal Cell Carcinoma
  • Neoplasms
  • Survival Rate
  • Recurrence
  18 Citations (Scopus)
• 2017

  Active heavy cigarette smoking is associated with poor survival in Japanese patients with advanced renal cell carcinoma: Sub-analysis of the multi-institutional national database of the Japanese Urological Association

  the Cancer Registration Committee of the Japanese Urological Association, Dec 1 2017, In: Japanese journal of clinical oncology. 47, 12, p. 1162-1169 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Cigarette Smoking
  • Renal Cell Carcinoma
  • Databases
  • Survival
  • Smoking
  1 Citation (Scopus)